Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04148001 Completed - Clinical trials for Homozygous Familial Hypercholesterolemia (HoFH)

Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients

Start date: December 4, 2019
Phase:
Study type: Observational

This study is designed to help identify patients with HoFH due to mutations in the LDLR as confirmed by genotyping.

NCT ID: NCT04147130 Completed - Polypharmacy Clinical Trials

MultiPAP Plus: Improving Prescription in Primary Care Patients With Multimorbidity and Polypharmacy

MultiPAP Plus
Start date: February 18, 2020
Phase: N/A
Study type: Interventional

This study assesses the effectiveness of a complex intervention in young-old patients with multimorbidity and polypharmacy aimed at improving physician drug prescription in primary care, measured by hospitalization-mortality at six 6 (T1), 12 (T2) and 18 (T3) months from baseline compared to usual care.

NCT ID: NCT04146896 Completed - Clinical trials for Diabetic Peripheral Neuropathic Pain

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

Start date: November 12, 2019
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy.

NCT ID: NCT04146805 Completed - Clinical trials for NASH - Nonalcoholic Steatohepatitis

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects

Start date: January 10, 2020
Phase: Phase 1
Study type: Interventional

A Phase 1a, Double Blind, Placebo-Controlled, Single-Center, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Volunteers

NCT ID: NCT04146337 Completed - Clinical trials for Carbapenem-Resistant Enterobacteriaceae Infection

Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae

Start date: October 12, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

2:1, open-label, single center, randomized controlled trial comparing FMT vs. no intervention for CRE carriers,

NCT ID: NCT04146259 Completed - Clinical trials for Hypoparathyroidism Postprocedural

Changes in Circulating Sclerostin Levels During Acute Postsurgical Hypoparathyroidism

Start date: January 1, 2017
Phase:
Study type: Observational

To investigate changes in sclerostin levels following acute post-thyroidectomy hypoparathyroidism

NCT ID: NCT04146090 Completed - Quality of Life Clinical Trials

Low-pressure vs Standard-pressure in Laparoscopic Cholecystectomy

Start date: October 23, 2019
Phase: N/A
Study type: Interventional

Background. Many studies have demonstrated reduced postoperative pain in patients undergoing lower pneumoperitoneum pressure level during laparoscopic cholecystectomy. However, most of them has shown a high risk of bias and low or very low quality of evidence. Considering the need to evaluate, not only the postoperative pain, but the effect of anesthesia and surgery on patient recovery and satisfaction, we have designed a prospective, randomised and double-blinded study to evaluate the quality of recovery, using the Quality of Recovery Questionnaire (QoR-40), in patients undergoing LC under low-pressure or standard pressure pneumoperitoneum. Methods. Eighty patients aged 18 to 65 years of age will be randomised into 2 groups: LP (low-pressure - 10mmHg) or S (standard - 14 mmHg) enrolled in the study. Anesthesia will be induced with remifentanil, propofol and rocuronium and the maintenance will be achieved with sevoflurane and remifentanil Anesthesiologists and surgeons will not have access to insufflation pressure display. The primary outcome will be assessed using the Quality of Recovery Questionnaire (QoR-40) which is a 40-item quality of recovery scoring system. In addition, the intraoperative rocuronium consumption, time to eye opening (time from the discontinuation of anesthetics to eye opening), post-operative nausea and vomiting, pain score, analgesic use, and length of PACU stay (time to Aldrete score ≥ 9) will be recorded.

NCT ID: NCT04146038 Completed - Clinical trials for Acute Myeloid Leukemia

Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease

Start date: October 26, 2020
Phase: Phase 2
Study type: Interventional

This phase II trial studies the side effects of salsalate when added to venetoclax and decitabine or azacitidine in treating patients with acute myeloid leukemia or myelodysplasia/myeloproliferative disease that has spread to other places in the body (advanced). Drugs used in chemotherapy, such as salsalate, venetoclax, decitabine, and azacitidine work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

NCT ID: NCT04145895 Completed - Clinical trials for Pediatric Post-operative Time to Return to Full Activity

Postoperative Activity Restrictions in Children

PARC
Start date: February 1, 2020
Phase: N/A
Study type: Interventional

This study will investigate the need for and length of postoperative activity restrictions in children following a laparoscopic appendectomy or inguinal hernia repair. Currently, no consensus exists and restrictions are based on doctors' experience and preference. Children and their parents/guardians will decide if they wish to participate in this study. Those who wish to participate and who are eligible to participate will decide which postoperative activity restrictions they would like the child to follow. The child will follow either 1) doctor-directed restrictions or 2) self-directed restrictions.A parent or guardian will complete a survey 1-3 months after the procedure, to assess patient and family satisfaction and patient outcome.

NCT ID: NCT04145830 Completed - Clinical trials for Glaucoma Treatment Using Focused Ultrasound

UCP Glaucoma Treatment for Primary Glaucoma in China

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

To collect safety and efficacy data on Ultrasound Cycle Plasty treatment (UCP) in primary glaucoma asian patients.